View in EDS HTML Full Text PDF Full Text

Neuropsychiatric post-acute sequelae of COVID-19: prevalence, severity, and impact of vaccination.

Saved in:
Bibliographic Details
Title: Neuropsychiatric post-acute sequelae of COVID-19: prevalence, severity, and impact of vaccination.
Authors: Elmazny, Alaa (AUTHOR), Magdy, Rehab (AUTHOR), Hussein, Mona (AUTHOR), Elsebaie, Eman H. (AUTHOR), Ali, Sara H. (AUTHOR), Abdel Fattah, Ali M. (AUTHOR), Hassan, Mahmoud (AUTHOR), Yassin, Ahmed (AUTHOR), Mahfouz, Noha A. (AUTHOR), Elsayed, Radwa M. (AUTHOR), Fathy, Wael (AUTHOR), Abdel-Hamid, Hoda M. (AUTHOR), Abdelbadie, Mohamed (AUTHOR), Soliman, Shaimaa H. (AUTHOR)
Source: European Archives of Psychiatry & Clinical Neuroscience. Sep2023, Vol. 273 Issue 6, p1349-1358. 10p. 4 Charts, 2 Graphs.
Subjects: COVID-19, Disease complications, Vaccination, Post-acute COVID-19 syndrome, COVID-19 pandemic, Tinnitus
Abstract: The potential long-term neuropsychiatric effects of COVID-19 are of global concern. This study aimed to determine the prevalence and predictors of neuropsychiatric post-acute sequelae of COVID-19 among Egyptian COVID-19 survivors and to study the impact of full vaccination before COVID-19 infection on the occurrence and severity of these manifestations. Three months after getting COVID-19 infection, 1638 COVID-19 survivors were screened by phone for possible neuropsychiatric sequelae. Subjects suspected to suffer from these sequelae were invited to a face-to-face interview for objective evaluation. They were requested to rate the severity of their symptoms using visual analogue scales (VAS). The mean age of participants was 38.28 ± 13 years. Only 18.6% were fully vaccinated before COVID-19 infection. Neuropsychiatric post-acute sequelae of COVID-19 were documented in 598 (36.5%) subjects, fatigue was the most frequent one (24.6%), followed by insomnia (16.4%), depression (15.3%), and anxiety (14.4%). Moderate and severe COVID-19 infection and non-vaccination increased the odds of developing post-COVID-19 neuropsychiatric manifestations by 2 times (OR 1.95, 95% CI = 1.415–2.683), 3.86 times (OR 3.86, 95% CI = 2.358–6.329), and 1.67 times (OR 1.67, 95% CI = 1.253–2.216), respectively. Fully vaccinated subjects before COVID-19 infection (n = 304) had significantly lesser severity of post-COVID-19 fatigue, ageusia/hypogeusia, dizziness, tinnitus, and insomnia (P value = 0.001, 0.008, < 0.001, 0.025, and 0.005, respectively) than non-vaccinated subjects. This report declared neuropsychiatric sequelae in 36.5% of Egyptian COVID-19 survivors, fatigue being the most prevalent. The effectiveness of COVID-19 vaccines in reducing the severity of some post-COVID-19 neuropsychiatric manifestations may improve general vaccine acceptance. [ABSTRACT FROM AUTHOR]
Copyright of European Archives of Psychiatry & Clinical Neuroscience is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 170399846
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Neuropsychiatric post-acute sequelae of COVID-19: prevalence, severity, and impact of vaccination.
– Name: Author
  Label: Authors
  Group: Au
  Data: &lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Elmazny%2C+Alaa%22&quot;&gt;Elmazny, Alaa&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Magdy%2C+Rehab%22&quot;&gt;Magdy, Rehab&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Hussein%2C+Mona%22&quot;&gt;Hussein, Mona&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Elsebaie%2C+Eman+H%2E%22&quot;&gt;Elsebaie, Eman H.&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Ali%2C+Sara+H%2E%22&quot;&gt;Ali, Sara H.&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Abdel+Fattah%2C+Ali+M%2E%22&quot;&gt;Abdel Fattah, Ali M.&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Hassan%2C+Mahmoud%22&quot;&gt;Hassan, Mahmoud&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Yassin%2C+Ahmed%22&quot;&gt;Yassin, Ahmed&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Mahfouz%2C+Noha+A%2E%22&quot;&gt;Mahfouz, Noha A.&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Elsayed%2C+Radwa+M%2E%22&quot;&gt;Elsayed, Radwa M.&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Fathy%2C+Wael%22&quot;&gt;Fathy, Wael&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Abdel-Hamid%2C+Hoda+M%2E%22&quot;&gt;Abdel-Hamid, Hoda M.&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Abdelbadie%2C+Mohamed%22&quot;&gt;Abdelbadie, Mohamed&lt;/searchLink&gt; (AUTHOR)&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Soliman%2C+Shaimaa+H%2E%22&quot;&gt;Soliman, Shaimaa H.&lt;/searchLink&gt; (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: &lt;searchLink fieldCode=&quot;JN&quot; term=&quot;%22European+Archives+of+Psychiatry+%26+Clinical+Neuroscience%22&quot;&gt;European Archives of Psychiatry &amp; Clinical Neuroscience&lt;/searchLink&gt;. Sep2023, Vol. 273 Issue 6, p1349-1358. 10p. 4 Charts, 2 Graphs.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: &lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22COVID-19%22&quot;&gt;COVID-19&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Disease+complications%22&quot;&gt;Disease complications&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Vaccination%22&quot;&gt;Vaccination&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Post-acute+COVID-19+syndrome%22&quot;&gt;Post-acute COVID-19 syndrome&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22COVID-19+pandemic%22&quot;&gt;COVID-19 pandemic&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Tinnitus%22&quot;&gt;Tinnitus&lt;/searchLink&gt;
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: The potential long-term neuropsychiatric effects of COVID-19 are of global concern. This study aimed to determine the prevalence and predictors of neuropsychiatric post-acute sequelae of COVID-19 among Egyptian COVID-19 survivors and to study the impact of full vaccination before COVID-19 infection on the occurrence and severity of these manifestations. Three months after getting COVID-19 infection, 1638 COVID-19 survivors were screened by phone for possible neuropsychiatric sequelae. Subjects suspected to suffer from these sequelae were invited to a face-to-face interview for objective evaluation. They were requested to rate the severity of their symptoms using visual analogue scales (VAS). The mean age of participants was 38.28 &#177; 13 years. Only 18.6% were fully vaccinated before COVID-19 infection. Neuropsychiatric post-acute sequelae of COVID-19 were documented in 598 (36.5%) subjects, fatigue was the most frequent one (24.6%), followed by insomnia (16.4%), depression (15.3%), and anxiety (14.4%). Moderate and severe COVID-19 infection and non-vaccination increased the odds of developing post-COVID-19 neuropsychiatric manifestations by 2 times (OR 1.95, 95% CI = 1.415–2.683), 3.86 times (OR 3.86, 95% CI = 2.358–6.329), and 1.67 times (OR 1.67, 95% CI = 1.253–2.216), respectively. Fully vaccinated subjects before COVID-19 infection (n = 304) had significantly lesser severity of post-COVID-19 fatigue, ageusia/hypogeusia, dizziness, tinnitus, and insomnia (P value = 0.001, 0.008, &lt; 0.001, 0.025, and 0.005, respectively) than non-vaccinated subjects. This report declared neuropsychiatric sequelae in 36.5% of Egyptian COVID-19 survivors, fatigue being the most prevalent. The effectiveness of COVID-19 vaccines in reducing the severity of some post-COVID-19 neuropsychiatric manifestations may improve general vaccine acceptance. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: &lt;i&gt;Copyright of European Archives of Psychiatry &amp; Clinical Neuroscience is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder&#39;s express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.&lt;/i&gt; (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=170399846
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00406-023-01557-2
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 10
        StartPage: 1349
    Subjects:
      – SubjectFull: COVID-19
        Type: general
      – SubjectFull: Disease complications
        Type: general
      – SubjectFull: Vaccination
        Type: general
      – SubjectFull: Post-acute COVID-19 syndrome
        Type: general
      – SubjectFull: COVID-19 pandemic
        Type: general
      – SubjectFull: Tinnitus
        Type: general
    Titles:
      – TitleFull: Neuropsychiatric post-acute sequelae of COVID-19: prevalence, severity, and impact of vaccination.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Elmazny, Alaa
      – PersonEntity:
          Name:
            NameFull: Magdy, Rehab
      – PersonEntity:
          Name:
            NameFull: Hussein, Mona
      – PersonEntity:
          Name:
            NameFull: Elsebaie, Eman H.
      – PersonEntity:
          Name:
            NameFull: Ali, Sara H.
      – PersonEntity:
          Name:
            NameFull: Abdel Fattah, Ali M.
      – PersonEntity:
          Name:
            NameFull: Hassan, Mahmoud
      – PersonEntity:
          Name:
            NameFull: Yassin, Ahmed
      – PersonEntity:
          Name:
            NameFull: Mahfouz, Noha A.
      – PersonEntity:
          Name:
            NameFull: Elsayed, Radwa M.
      – PersonEntity:
          Name:
            NameFull: Fathy, Wael
      – PersonEntity:
          Name:
            NameFull: Abdel-Hamid, Hoda M.
      – PersonEntity:
          Name:
            NameFull: Abdelbadie, Mohamed
      – PersonEntity:
          Name:
            NameFull: Soliman, Shaimaa H.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: Sep2023
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 09401334
          Numbering:
            – Type: volume
              Value: 273
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: European Archives of Psychiatry & Clinical Neuroscience
              Type: main
ResultId 1